The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126173611 12617361 1 I 20121212 20160720 20160803 20160803 EXP GB-AUROBINDO-AUR-APL-2016-09699 AUROBINDO 57.00 YR F Y 0.00000 20160803 MD GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126173611 12617361 1 PS RIBAVIRIN. RIBAVIRIN 1 Oral 1200 MG, UNK Y U 79111 1200 MG
126173611 12617361 2 SS PEGINTERFERON ALFA-2B PEGINTERFERON ALFA-2B 1 Subcutaneous 150 ?G, EVERY WEEK 42.8569984 UG Y U 0 150 UG /wk
126173611 12617361 3 SS TELAPREVIR TELAPREVIR 1 Oral 2250 MG, UNK Y U 0 2250 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126173611 12617361 1 Chronic hepatitis C
126173611 12617361 2 Chronic hepatitis C
126173611 12617361 3 Chronic hepatitis C

Outcome of event

Event ID CASEID OUTC COD
126173611 12617361 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126173611 12617361 Anaemia
126173611 12617361 Arthralgia
126173611 12617361 Depressed mood
126173611 12617361 Dry mouth
126173611 12617361 Dyspnoea
126173611 12617361 Eye swelling
126173611 12617361 Fatigue
126173611 12617361 Gingival bleeding
126173611 12617361 Influenza like illness
126173611 12617361 Mouth ulceration
126173611 12617361 Nausea
126173611 12617361 Neutropenia
126173611 12617361 Pruritus
126173611 12617361 Rash erythematous

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126173611 12617361 1 20121210 20130606 0
126173611 12617361 2 20121210 20130603 0
126173611 12617361 3 20121210 20130301 0